NOX

2.94%

6.6¢ noxopharm limited

Hi RBx,Are you able to ask Dr. Kelly why there was no interest...

First 3 Last

Share
Profile

Follow
19661966

354 Posts.

37

06/01/23

17:29

Post #: 65567955
Share

Originally posted by RBx: ↑

I wrote to Professor Kelly and asked him to shed light on his involvement with Filamon; and for his view on Noxopharm. This is his reply, which he has allowed me to publish here.

Thanks for bringing to my attention the comment on Hot Copper about the new company, Filamon.

As you know, I am heavily invested in NOX both financially andemotionally. I discovered idronoxil in the first place, and it was a verypersonal experience with cancer that led to the discovery of the Veyondaformulation and the DARRT treatment regimen. The CEP and LuPIN programs and theexciting relationship with Hudson and the mRNA drug pipeline were all initiatedby me. I retired from NOX because at age 77 it was time to hand the day to dayrunning of the Company over to others, and those ‘others’ deserved to be ableto run the Company without the ghost of a founder haunting the corridors. It’spainful to see the SP where it is, but I remain supremely confident that thetechnology platforms will prove their worth sooner rather than later.

I was asked to help get Filamon up and running, and the science wasexciting enough to get me out of retirement. I have been through the prostatecancer experience – the biopsies, weeks of radiotherapy, 4 years of chemicalcastration therapy playing havoc with your brain and body, and finallymetastatic tumours causing pain and paralysis. With Professor de Souza’s andVeyonda’s help, I cleared my body of all cancer 8 years ago and my hope is tosee other men derive the same benefit from Veyonda.

But I have been involved in medical science long enough to know thatcuring cancer is going to take several silver bullets, not a single silverbullet. That is why I agreed to become involved in another opportunity to helpother men not have to go through what I went through. What Filamon is doingcomplements, not replaces, what NOX is doing.

Expand

Hi RBx,

Are you able to ask Dr. Kelly why there was no interest in Veyonda from Novartis after the LUPIN trial which showed such great results ?

and him alluding on many occasions that there might be a commercial offer/arrangement coming from Novartis.

NOX Price at posting: 13.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

There are more pages in this discussion • 11 more messages in this thread...

First 3 Last

Add NOX (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change -0.002(2.94%)		Mkt cap ! $19.28M

Open	High	Low	Value	Volume
6.7¢	6.9¢	6.6¢	$13.31K	198.1K

Buyers (Bids)

No.	Vol.	Price($)
1	1137	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.7¢	22400	1

View Market Depth

No.	Vol.	Price($)
1	1137	0.066
1	100000	0.064
3	47786	0.061
4	105033	0.060
2	120000	0.059

Price($)	Vol.	No.
0.079	12000	2
0.080	12099	2
0.081	22345	2
0.083	40000	1
0.090	25689	3

Last trade - 15.50pm 28/06/2024 (20 minute delay)

NOX (ASX) Chart

Hi RBx,Are you able to ask Dr. Kelly why there was no interest...

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi RBx,Are you able to ask Dr. Kelly why there was no interest...

Top Stories

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News